Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Protein Page:
CASP12 (mouse)

Overview
CASP12 Has no protease activity. May reduce cytokine release in response to bacterial lipopolysaccharide during infections. Reduces activation of NF-kappa-B in response to TNF. Detected in heart, kidney, liver, lung, pancreas, small intestine, spleen, stomach, thymus and testis. Belongs to the peptidase C14A family. 3 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: EC 3.4.22.-; Protease
Cellular Component: cytosol; endoplasmic reticulum; intracellular membrane-bound organelle; nucleus
Molecular Function: cysteine-type endopeptidase activity; cysteine-type peptidase activity; endopeptidase activity; hydrolase activity; peptidase activity; protease binding; protein binding
Biological Process: apoptosis; positive regulation of apoptosis; positive regulation of caspase activity; protein autoprocessing; proteolysis; regulation of apoptosis; unfolded protein response
Reference #:  O08736 (UniProtKB)
Alt. Names/Synonyms: CASP-12; Casp12; caspase 12; Caspase-12; CASPC
Gene Symbols: Casp12
Molecular weight: 47,854 Da
Basal Isoelectric point: 5.95  Predict pI for various phosphorylation states
CST Pathways:  Apoptosis Regulation  |  ErbB/HER Signaling
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

CASP12

Protein Structure Not Found.


STRING  |  BioGPS  |  Scansite  |  Pfam  |  ENZYME  |  Phospho.ELM  |  NetworKIN  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 LTP 

LTP: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 HTP 

HTP: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       mouse

 
0 1 S85 ANSQEQLSLQFSNDE
0 1 N90 QLSLQFSNDEDDGPQ
0 2 S104‑p QKICTPSsPSESKRK
0 1 T220 VVLKENLTAQEMETE
0 1 S332‑p LSCKWNNsITKAHVE
0 1 S408‑p MPTIERVsMTRyFyL
0 1 Y412‑p ERVsMTRyFyLFPGN
0 1 Y414‑p VsMTRyFyLFPGN__
  human

 
S85 WNSKKQLSSDISSDG
S90 QLSSDISSDGEREAN
- gap
T142‑p VVIKENLtAQEMETA
A254 QGNICNDAVTKAHVE
S330 LPTIERLSMTRYFYL
Y334 ERLSMTRYFYLFPGN
Y336 LSMTRYFYLFPGN__
  rat

 
S85‑p ANSDKQLsLQFPsDD
S90‑p QLsLQFPsDDEEDEL
S105 QKMFTPSSASESRGK
T221 VVIKENLTAQEMETE
S333 LSHRWNNSITKAHVE
S409 MPTIERVSMTRYFYL
Y413 ERVSMTRYFYLFPGN
Y415 VSMTRYFYLFPGN__
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.